171 related articles for article (PubMed ID: 35490384)
1. Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.
Plana-Pla A; García B; Munera-Campos M; Catasus N; Serra Arenas E; Blanco I; Castellanos Perez E; Bielsa I;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1632-1640. PubMed ID: 35490384
[TBL] [Abstract][Full Text] [Related]
2. Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.
Castellanos E; Plana A; Carrato C; Carrió M; Rosas I; Amilibia E; Roca-Ribas F; Hostalot C; Castillo A; Ros A; Quer A; Becerra JL; Salvador H; Lázaro C; Blanco I; Serra E; Bielsa I;
JAMA Dermatol; 2018 Mar; 154(3):341-346. PubMed ID: 29322178
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
4. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?
Leverkus M; Kluwe L; Röll EM; Becker G; Bröcker EB; Mautner VF; Hamm H
Br J Dermatol; 2003 Apr; 148(4):804-9. PubMed ID: 12752143
[TBL] [Abstract][Full Text] [Related]
5. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.
Evans DG; Mason S; Huson SM; Ponder M; Harding AE; Strachan T
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):361-6. PubMed ID: 9120449
[TBL] [Abstract][Full Text] [Related]
6. Contiguous conventional and plexiform schwannomas. Report of two cases.
White JB; Scheithauer BW; Amrami KK; Babovic-Vuksanovic D; Spinner RJ
J Neurosurg; 2006 Feb; 104(2):319-24. PubMed ID: 16509508
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2.
Plana-Pla A; Bielsa-Marsol I; Carrato-Moñino C;
Actas Dermosifiliogr; 2017 Sep; 108(7):630-636. PubMed ID: 28237041
[TBL] [Abstract][Full Text] [Related]
8. Multiple cutaneous plexiform schwannomas as initial presentation of neurofibromatosis 2 in a 9-year-old.
Nguyen TV; Matthews MR; Barrera FF; Browning JC
Pediatr Dermatol; 2012; 29(4):536-8. PubMed ID: 21906157
[TBL] [Abstract][Full Text] [Related]
9. A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?
Murray AJ; Hughes TA; Neal JW; Howard E; Evans DG; Harper PS
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):269-71. PubMed ID: 16421138
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
[TBL] [Abstract][Full Text] [Related]
11. Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.
Legoupil S; Bessis D; Picard F; Mallet S; Mazereeuw J; Phan A; Dupin-Deguine D; Kalamarides M; ; Chiaverini C
Orphanet J Rare Dis; 2022 Jun; 17(1):242. PubMed ID: 35729665
[TBL] [Abstract][Full Text] [Related]
12. Gastric plexiform schwannoma in association with neurofibromatosis type 2.
Kudose S; Kyriakos M; Awad MM
Clin J Gastroenterol; 2016 Dec; 9(6):352-357. PubMed ID: 27696205
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous plexiform schwannoma associated with neurofibromatosis type 2.
Val-Bernal JF; Figols J; Vázquez-Barquero A
Cancer; 1995 Oct; 76(7):1181-6. PubMed ID: 8630895
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
15. Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.
Wolkenstein P; Benchikhi H; Zeller J; Wechsler J; Revuz J
Dermatology; 1997; 195(3):228-31. PubMed ID: 9407167
[TBL] [Abstract][Full Text] [Related]
16. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
17. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
18. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
19. Multiple isolated cutaneous plexiform schwannomas.
Attia EA; Yassin M; Lasheen MA; Salem SA; Khafagy NH
Indian J Dermatol Venereol Leprol; 2011; 77(5):594-6. PubMed ID: 21860160
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
